CAPITAL STOCK (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized	200,000,000		200,000,000		200,000,000
Common stock, par value	$ 0.001		$ 0.001		$ 0.001
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross			400,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares		300,000	100,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares		25,000
Expenses related to options	$ 380,045		$ 380,045
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants outstanding	2,256,296		2,256,296
Issuance of warrants, description			Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,244,108 shares of our Common Stock at an exercise price of $2.00 per share consisting of 1% of the warrants until August 2024, and 99% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.
Warrant One [Member] | Until April 2025 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued to purchase common stock	911		911
Warrants exercise price	$ 1.65		$ 1.65
Warrant Two [Member] | Until August 2024 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued to purchase common stock	1,244,108		1,244,108
Warrants exercise price	$ 2.00		$ 2.00
Warrant Three [Member] | Until September 2024 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued to purchase common stock	474,966		474,966
Warrants exercise price	$ 2.40		$ 2.40
Warrant Four [Member] | Until November 2025 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued to purchase common stock	386,311		386,311
Warrants exercise price	$ 2.63		$ 2.63
Warrant Five [Member] | Until February 2024 [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants issued to purchase common stock	150,000		150,000
Warrants exercise price	$ 6.72		$ 6.72
Employees, Board of Directors, Advisory Committee [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for employees benefit, shares			1,431,227
Shares issued for employees benefit, value			$ 2,977,845
New Issuance of Shares [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock issued new shares, shares			1,431,227